Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

OTC Healthcare in the Netherlands to 2011

Published by: Datamonitor

Published: Aug. 1, 2008 - 189 Pages


Table of Contents


Chapter 1 EXECUTIVE SUMMARY
Summary Market Level - OTC Healthcare
Summary category level - Analgesics
Summary category level - Cough and Cold Preparations
Summary category level - Traditional Medicines
Summary category level - First Aid Kits
Summary category level - Indigestion Preparations
Summary category level - Vitamins and Minerals
Summary category level - Plasters & Bandages
Summary category level - Medicated Skin Products
Summary category level - Other OTC Healthcare Products
Summary category level - Topical OTC Medicines
Chapter 2 INTRODUCTION
What is this report about?
How to use this report
Market Definition
Chapter 3 MARKET OVERVIEW
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 4 LEADING COMPANY PROFILES
Pfizer Inc
Bayer AG
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 15 COUNTRY COMPARISON
Value
Market Share
Chapter 16 NEW PRODUCT DEVELOPMENT
Product launches over time
Recent product launches
Chapter 17 NETHERLANDS SOCIOECONOMIC PROFILE
Country Overview
Key Facts
Political Overview
Netherlands Economic Overview
Chapter 18 NETHERLANDS MACROECONOMIC PROFILE
Macroeconomic Indicators
Chapter 19 RESEARCH METHODOLOGY
Methodology overview
Secondary research
Market modelling
Primary research
Data finalisation
Ongoing research
Chapter 20 APPENDIX
Future readings
How to contact experts in your industry
LIST OF FIGURES
Figure 1: Netherlands OTC Healthcare value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 2: Netherlands OTC Healthcare category growth comparison, by value, 2001-2011
Figure 3: Netherlands OTC Healthcare company share, by value, 2005-2006 (%)
Figure 4: Netherlands Analgesics value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 5: Netherlands Analgesics category growth comparison, by value, 2001-2011
Figure 6: Netherlands Analgesics company share, by value, 2005-2006 (%)
Figure 7: Netherlands Cough and Cold Preparations value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 8: Netherlands Cough and Cold Preparations category growth comparison, by value, 2001-2011
Figure 9: Netherlands Cough and Cold Preparations company share, by value, 2005-2006 (%)
Figure 10: Netherlands Traditional Medicines value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 11: Netherlands Traditional Medicines company share, by value, 2005-2006 (%)
Figure 12: Netherlands First Aid Kits value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 13: Netherlands First Aid Kits company share, by value, 2005-2006 (%)
Figure 14: Netherlands Indigestion Preparations value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 15: Netherlands Indigestion Preparations category growth comparison, by value, 2001-2011
Figure 16: Netherlands Indigestion Preparations company share, by value, 2005-2006 (%)
Figure 17: Netherlands Vitamins and Minerals value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 18: Netherlands Vitamins and Minerals category growth comparison, by value, 2001-2011
Figure 19: Netherlands Vitamins and Minerals company share, by value, 2005-2006 (%)
Figure 20: Netherlands Plasters & Bandages value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 21: Netherlands Plasters & Bandages category growth comparison, by value, 2001-2011
Figure 22: Netherlands Plasters & Bandages company share, by value, 2005-2006 (%)
Figure 23: Netherlands Medicated Skin Products value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 24: Netherlands Medicated Skin Products category growth comparison, by value, 2001-2011
Figure 25: Netherlands Medicated Skin Products company share, by value, 2005-2006 (%)
Figure 26: Netherlands Other OTC Healthcare Products value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 27: Netherlands Other OTC Healthcare Products category growth comparison, by value, 2001-2011
Figure 28: Netherlands Other OTC Healthcare Products company share, by value, 2005-2006 (%)
Figure 29: Netherlands Topical OTC Medicines value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 30: Netherlands Topical OTC Medicines category growth comparison, by value, 2001-2011
Figure 31: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries
Figure 32: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries)
Figure 33: Map of Netherlands
Figure 34: Annual data review process
LIST OF TABLES
Table 1: OTC Healthcare category definitions
Table 2: Netherlands OTC Healthcare value, 2001-2006 (EUR m, nominal prices)
Table 3: Netherlands OTC Healthcare value forecast, 2006-2011 (EUR m, nominal prices)
Table 4: Netherlands OTC Healthcare value, 2001-2006 (US$ m nominal prices)
Table 5: Netherlands OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices)
Table 6: Netherlands OTC Healthcare brand share, by value, 2005-2006 (%)
Table 7: Netherlands OTC Healthcare value, by brand 2005-2006 (EUR m nominal prices)
Table 8: Netherlands OTC Healthcare company share by value, 2005-2006 (%)
Table 9: Netherlands OTC Healthcare value, by company, 2005-2006 (EUR m nominal prices)
Table 10: Netherlands OTC Healthcare expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 11: Netherlands OTC Healthcare forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 12: Netherlands OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices)
Table 13: Netherlands OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 14: Pfizer Inc Key Facts
Table 15: Bayer AG Key Facts
Table 16: Netherlands Analgesics value, 2001-2006 (EUR m, nominal prices)
Table 17: Netherlands Analgesics value forecast, 2006-2011 (EUR m, nominal prices)
Table 18: Netherlands Analgesics value, 2001-2006 (US$ m nominal prices)
Table 19: Netherlands Analgesics value forecast, 2006-2011 (US$ m nominal prices)
Table 20: Netherlands Analgesics brand share, by value, 2005-2006 (%)
Table 21: Netherlands Analgesics value, by brand 2005-2006 (EUR m nominal prices)
Table 22: Netherlands Analgesics company share by value, 2005-2006 (%)
Table 23: Netherlands Analgesics value, by company, 2005-2006 (EUR m nominal prices)
Table 24: Netherlands Analgesics expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 25: Netherlands Analgesics forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 26: Netherlands Analgesics expenditure per capita, 2001-2006 (US$ nominal prices)
Table 27: Netherlands Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 28: Netherlands Cough and Cold Preparations value, 2001-2006 (EUR m, nominal prices)
Table 29: Netherlands Cough and Cold Preparations value forecast, 2006-2011 (EUR m, nominal prices)
Table 30: Netherlands Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices)
Table 31: Netherlands Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices)
Table 32: Netherlands Cough and Cold Preparations brand share, by value, 2005-2006 (%)
Table 33: Netherlands Cough and Cold Preparations value, by brand 2005-2006 (EUR m nominal prices)
Table 34: Netherlands Cough and Cold Preparations company share by value, 2005-2006 (%)
Table 35: Netherlands Cough and Cold Preparations value, by company, 2005-2006 (EUR m nominal prices)
Table 36: Netherlands Cough and Cold Preparations expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 37: Netherlands Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 38: Netherlands Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
Table 39: Netherlands Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 40: Netherlands Traditional Medicines value, 2001-2006 (EUR m, nominal prices)
Table 41: Netherlands Traditional Medicines value forecast, 2006-2011 (EUR m, nominal prices)
Table 42: Netherlands Traditional Medicines value, 2001-2006 (US$ m nominal prices)
Table 43: Netherlands Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices)
Table 44: Netherlands Traditional Medicines brand share, by value, 2005-2006 (%)
Table 45: Netherlands Traditional Medicines value, by brand 2005-2006 (EUR m nominal prices)
Table 46: Netherlands Traditional Medicines company share by value, 2005-2006 (%)
Table 47: Netherlands Traditional Medicines value, by company, 2005-2006 (EUR m nominal prices)
Table 48: Netherlands Traditional Medicines expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 49: Netherlands Traditional Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 50: Netherlands Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
Table 51: Netherlands Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 52: Netherlands First Aid Kits value, 2001-2006 (EUR m, nominal prices)
Table 53: Netherlands First Aid Kits value forecast, 2006-2011 (EUR m, nominal prices)
Table 54: Netherlands First Aid Kits value, 2001-2006 (US$ m nominal prices)
Table 55: Netherlands First Aid Kits value forecast, 2006-2011 (US$ m nominal prices)
Table 56: Netherlands First Aid Kits brand share, by value, 2005-2006 (%)
Table 57: Netherlands First Aid Kits value, by brand 2005-2006 (EUR m nominal prices)
Table 58: Netherlands First Aid Kits company share by value, 2005-2006 (%)
Table 59: Netherlands First Aid Kits value, by company, 2005-2006 (EUR m nominal prices)
Table 60: Netherlands First Aid Kits expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 61: Netherlands First Aid Kits forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 62: Netherlands First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices)
Table 63: Netherlands First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 64: Netherlands Indigestion Preparations value, 2001-2006 (EUR m, nominal prices)
Table 65: Netherlands Indigestion Preparations value forecast, 2006-2011 (EUR m, nominal prices)
Table 66: Netherlands Indigestion Preparations value, 2001-2006 (US$ m nominal prices)
Table 67: Netherlands Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices)
Table 68: Netherlands Indigestion Preparations brand share, by value, 2005-2006 (%)
Table 69: Netherlands Indigestion Preparations value, by brand 2005-2006 (EUR m nominal prices)
Table 70: Netherlands Indigestion Preparations company share by value, 2005-2006 (%)
Table 71: Netherlands Indigestion Preparations value, by company, 2005-2006 (EUR m nominal prices)
Table 72: Netherlands Indigestion Preparations expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 73: Netherlands Indigestion Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 74: Netherlands Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
Table 75: Netherlands Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 76: Netherlands Vitamins and Minerals value, 2001-2006 (EUR m, nominal prices)
Table 77: Netherlands Vitamins and Minerals value forecast, 2006-2011 (EUR m, nominal prices)
Table 78: Netherlands Vitamins and Minerals value, 2001-2006 (US$ m nominal prices)
Table 79: Netherlands Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices)
Table 80: Netherlands Vitamins and Minerals brand share, by value, 2005-2006 (%)
Table 81: Netherlands Vitamins and Minerals value, by brand 2005-2006 (EUR m nominal prices)
Table 82: Netherlands Vitamins and Minerals company share by value, 2005-2006 (%)
Table 83: Netherlands Vitamins and Minerals value, by company, 2005-2006 (EUR m nominal prices)
Table 84: Netherlands Vitamins and Minerals expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 85: Netherlands Vitamins and Minerals forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 86: Netherlands Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices)
Table 87: Netherlands Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 88: Netherlands Plasters & Bandages value, 2001-2006 (EUR m, nominal prices)
Table 89: Netherlands Plasters & Bandages value forecast, 2006-2011 (EUR m, nominal prices)
Table 90: Netherlands Plasters & Bandages value, 2001-2006 (US$ m nominal prices)
Table 91: Netherlands Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices)
Table 92: Netherlands Plasters & Bandages brand share, by value, 2005-2006 (%)
Table 93: Netherlands Plasters & Bandages value, by brand 2005-2006 (EUR m nominal prices)
Table 94: Netherlands Plasters & Bandages company share by value, 2005-2006 (%)
Table 95: Netherlands Plasters & Bandages value, by company, 2005-2006 (EUR m nominal prices)
Table 96: Netherlands Plasters & Bandages expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 97: Netherlands Plasters & Bandages forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 98: Netherlands Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices)
Table 99: Netherlands Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 100: Netherlands Medicated Skin Products value, 2001-2006 (EUR m, nominal prices)
Table 101: Netherlands Medicated Skin Products value forecast, 2006-2011 (EUR m, nominal prices)
Table 102: Netherlands Medicated Skin Products value, 2001-2006 (US$ m nominal prices)
Table 103: Netherlands Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices)
Table 104: Netherlands Medicated Skin Products brand share, by value, 2005-2006 (%)
Table 105: Netherlands Medicated Skin Products value, by brand 2005-2006 (EUR m nominal prices)
Table 106: Netherlands Medicated Skin Products company share by value, 2005-2006 (%)
Table 107: Netherlands Medicated Skin Products value, by company, 2005-2006 (EUR m nominal prices)
Table 108: Netherlands Medicated Skin Products expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 109: Netherlands Medicated Skin Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 110: Netherlands Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices)
Table 111: Netherlands Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 112: Netherlands Other OTC Healthcare Products value, 2001-2006 (EUR m, nominal prices)
Table 113: Netherlands Other OTC Healthcare Products value forecast, 2006-2011 (EUR m, nominal prices)
Table 114: Netherlands Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices)
Table 115: Netherlands Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices)
Table 116: Netherlands Other OTC Healthcare Products brand share, by value, 2005-2006 (%)
Table 117: Netherlands Other OTC Healthcare Products value, by brand 2005-2006 (EUR m nominal prices)
Table 118: Netherlands Other OTC Healthcare Products company share by value, 2005-2006 (%)
Table 119: Netherlands Other OTC Healthcare Products value, by company, 2005-2006 (EUR m nominal prices)
Table 120: Netherlands Other OTC Healthcare Products expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 121: Netherlands Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 122: Netherlands Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices)
Table 123: Netherlands Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 124: Netherlands Topical OTC Medicines value, 2001-2006 (EUR m, nominal prices)
Table 125: Netherlands Topical OTC Medicines value forecast, 2006-2011 (EUR m, nominal prices)
Table 126: Netherlands Topical OTC Medicines value, 2001-2006 (US$ m nominal prices)
Table 127: Netherlands Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices)
Table 128: Netherlands Topical OTC Medicines brand share, by value, 2005-2006 (%)
Table 129: Netherlands Topical OTC Medicines value, by brand 2005-2006 (EUR m nominal prices)
Table 130: Netherlands Topical OTC Medicines company share by value, 2005-2006 (%)
Table 131: Netherlands Topical OTC Medicines value, by company, 2005-2006 (EUR m nominal prices)
Table 132: Netherlands Topical OTC Medicines expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 133: Netherlands Topical OTC Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 134: Netherlands Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
Table 135: Netherlands Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 136: Global OTC Healthcare market value, 2006
Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries
Table 138: Leading players - Top 5 countries
Table 139: Netherlands OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006
Table 140: Netherlands OTC Healthcare new product launches (reports), by flavor and fragrances 2006
Table 141: Netherlands OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006
Table 142: Netherlands OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006
Table 143: Netherlands OTC Healthcare new product launches (reports) - Recent 5 launches
Table 144: Netherlands Key Facts
Table 145: Netherlands population, by age group, 2000-2005 (millions)
Table 146: Netherlands population forecast, by age group, 2005-2010 (millions)
Table 147: Netherlands population, by gender, 2000-2005 (millions)
Table 148: Netherlands population forecast, by gender, 2005-2010 (millions)
Table 149: Netherlands real GDP, 2000-2005 (EUR bn, 2005 prices)
Table 150: Netherlands real GDP forecast, 2005-2010 (EUR bn, 2005 prices)
Table 151: Netherlands nominal GDP, 2000-2005 (EUR bn, nominal prices)
Table 152: Netherlands real GDP, 2000-2005 (US$ bn, 2005 prices)
Table 153: Netherlands real GDP forecast, 2005-2010 (US$ bn, 2005 prices
Table 154: Netherlands consumer price index, 2000-2005 (2000=100)
Table 155: Netherlands consumer price index, 2005-2010 (2000=100)
Table 156: Netherlands exchange rate, 2000-2005

Abstract

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in the Netherlands. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope
  • Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
  • Provides market value, volume, expenditure and consumption data by market, segment and subsegment
  • Includes company and brand share data by categories
Highlights

The market for OTC Healthcare in the Netherlands increased between 2001-2006, growing at an average annual rate of 3.4%.

The leading company in the market in 2006 was Pfizer Inc. The second-largest player was Bayer AG with Bional in third place.

Reasons to Purchase
  • Discover the major quantitative trends affecting the OTC Healthcare markets
  • Understand consumers' consumption and expenditure patterns
  • Understand the future direction of the market with reliable historical data and full five year forecasting


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009